FIELD: organic chemistry, peptides, biochemistry.
SUBSTANCE: invention relates to compounds of the formula (I): , wherein R means hydrogen atom; R1 means carbocyclic aryl substituted optionally with halogen atom or (carbocyclic aryl or biaryl)-(lower)-alkyl substituted optionally with trifluoromethyl group or halogen atom; alk means (lower)-alkylene; R3 means hydrogen atom or acyl substituted optionally with alkoxy-group, morpholinyl, triazolyl or piperazinyl groups; R4 means hydrogen atom substituted optionally with methoxy-(lower)-alkyl or oxacycloalkyl group; R5 means hydrogen atom or (lower)-alkyl; R6 means (lower)-alkyl; R7 means (lower)-alkyl; or R6 and R7 in common with carbon atom to which they are bound mean 3-10-membered cycloalkylidene; X means -O-,-S(O)n-, -NHCO- wherein n = 0 or 2; -COOR2 means carboxyl or derivative of carboxyl group as a pharmaceutically acceptable ester wherein R2 is chosen from (lower)-alkyl, morpholine carbonylmethyl, dimethylaminocarbonylmethyl or diethylaminocarbonylmethyl, or its pharmaceutically acceptable salt. Proposed compounds are used as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase and as inhibitor of endothelin-converting enzyme also.
EFFECT: valuable medicinal and biochemical properties of dipeptides.
8 cl, 7 ex
Authors
Dates
2007-05-10—Published
2002-05-14—Filed